111 related articles for article (PubMed ID: 35102088)
1. Association of urinary angiotensinogen with renal arteriolar remodeling in chronic kidney disease.
Kanamitsu T; Kohagura K; Zamami R; Nakamura T; Oshiro N; Miyagi T; Nakamura K; Ohya Y
J Hypertens; 2022 Apr; 40(4):650-657. PubMed ID: 35102088
[TBL] [Abstract][Full Text] [Related]
2. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.
Kobori H; Alper AB; Shenava R; Katsurada A; Saito T; Ohashi N; Urushihara M; Miyata K; Satou R; Hamm LL; Navar LG
Hypertension; 2009 Feb; 53(2):344-50. PubMed ID: 19075095
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intrarenal renin-angiotensin system activity in diabetic versus non-diabetic patients with overt proteinuria.
Park JH; Jang HR; Lee JH; Lee JE; Huh W; Lee KB; Kwon YJ; Do JY; Kim HY; Kim YG
Nephrology (Carlton); 2015 Apr; 20(4):279-85. PubMed ID: 25522682
[TBL] [Abstract][Full Text] [Related]
4. Effect of urinary angiotensinogen and high-salt diet on blood pressure in patients with chronic kidney disease: results from the Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Kim HY; Choi HS; Kim CS; Bae EH; Ma SK; Sung SA; Han SH; Oh KH; Ahn C; Kim SW
Korean J Intern Med; 2021 May; 36(3):659-667. PubMed ID: 33028070
[TBL] [Abstract][Full Text] [Related]
5. Urinary angiotensinogen predicts progressive chronic kidney disease after an episode of experimental acute kidney injury.
Cui S; Wu L; Feng X; Su H; Zhou Z; Luo W; Su C; Li Y; Shi M; Yang Z; Cao W
Clin Sci (Lond); 2018 Oct; 132(19):2121-2133. PubMed ID: 30224346
[TBL] [Abstract][Full Text] [Related]
6. Reduction in urinary angiotensinogen levels and improvement of proteinuria by renin-angiotensin system blockade in pediatric chronic kidney disease patients with very low birth weight.
Yamamura-Miyazaki N; Michigami T; Satomura K; Urushihara M; Kagami S; Yamamoto K
Pediatr Nephrol; 2020 Jul; 35(7):1307-1314. PubMed ID: 32162100
[TBL] [Abstract][Full Text] [Related]
7. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
[TBL] [Abstract][Full Text] [Related]
8. The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy.
Tang Z; Wang Y; Tao L; Guo Y; Zheng Y; Zheng D
BMC Nephrol; 2018 Dec; 19(1):357. PubMed ID: 30541470
[TBL] [Abstract][Full Text] [Related]
9. Urinary Angiotensinogen and Progression of Chronic Kidney Disease: Results from KNOW-CKD Study.
Suh SH; Oh TR; Choi HS; Yang EM; Kim CS; Bae EH; Ma SK; Oh KH; Jung JY; Hyun YY; Kim SW
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139118
[TBL] [Abstract][Full Text] [Related]
10. The Role of Urinary Angiotensinogen in Kidney Interstitial Inflammation and Renal Prognosis.
Dou Y; Song D; Wang C; Liu D; Cheng G; Xiao J; Zhao Z
Iran J Kidney Dis; 2019 Nov; 13(6):372-379. PubMed ID: 31880583
[TBL] [Abstract][Full Text] [Related]
11. Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy.
Kim YG; Song SB; Lee SH; Moon JY; Jeong KH; Lee TW; Ihm CG
Clin Exp Nephrol; 2011 Oct; 15(5):720-726. PubMed ID: 21695414
[TBL] [Abstract][Full Text] [Related]
12. Increased urinary angiotensinogen is an effective marker of chronic renal impairment in very low birth weight children.
Nishizaki N; Hirano D; Nishizaki Y; Fujinaga S; Nagata S; Ohtomo Y; Kaneko K; Shimizu T
Clin Exp Nephrol; 2014 Aug; 18(4):642-8. PubMed ID: 24178957
[TBL] [Abstract][Full Text] [Related]
13. Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients.
Urushihara M; Nagai T; Kinoshita Y; Nishiyama S; Suga K; Ozaki N; Jamba A; Kondo S; Kobori H; Kagami S
Pediatr Nephrol; 2015 Jun; 30(6):975-82. PubMed ID: 25523477
[TBL] [Abstract][Full Text] [Related]
14. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of urinary angiotensinogen and renin as potential biomarkers in patients with overt proteinuria.
Jang HR; Jeon J; Park JH; Lee JE; Huh W; Oh HY; Kim YG
Transl Res; 2014 Nov; 164(5):400-10. PubMed ID: 24929205
[TBL] [Abstract][Full Text] [Related]
16. Urinary renin-angiotensin markers in polycystic kidney disease.
Salih M; Bovée DM; Roksnoer LCW; Casteleijn NF; Bakker SJL; Gansevoort RT; Zietse R; Danser AHJ; Hoorn EJ
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F874-F881. PubMed ID: 28747358
[TBL] [Abstract][Full Text] [Related]
17. Increased urinary angiotensinogen precedes the onset of albuminuria in normotensive type 2 diabetic patients.
Zhuang Z; Bai Q; A L; Liang Y; Zheng D; Wang Y
Int J Clin Exp Pathol; 2015; 8(9):11464-9. PubMed ID: 26617876
[TBL] [Abstract][Full Text] [Related]
18. Urinary angiotensinogen accurately reflects intrarenal Renin-Angiotensin system activity.
Urushihara M; Kondo S; Kagami S; Kobori H
Am J Nephrol; 2010; 31(4):318-25. PubMed ID: 20160435
[TBL] [Abstract][Full Text] [Related]
19. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease.
Mills KT; Kobori H; Hamm LL; Alper AB; Khan IE; Rahman M; Navar LG; Liu Y; Browne GM; Batuman V; He J; Chen J
Nephrol Dial Transplant; 2012 Aug; 27(8):3176-81. PubMed ID: 22399491
[TBL] [Abstract][Full Text] [Related]
20. The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function.
Matsuyama T; Ohashi N; Ishigaki S; Isobe S; Tsuji N; Fujikura T; Tsuji T; Kato A; Miyajima H; Yasuda H
Intern Med; 2018 Nov; 57(22):3241-3247. PubMed ID: 29984779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
